A Case of the Drug Reaction with Eosinophilia and Systemic Symptom (DRESS) Following Isoniazid Treatment |
Lee, Jin-Yong
(Department of Internal Medicine, Soonchunhyang University Bucheon Hospital)
Seol, Yun-Jae (Department of Internal Medicine, Soonchunhyang University Bucheon Hospital) Shin, Dong-Woo (Department of Internal Medicine, Soonchunhyang University Bucheon Hospital) Kim, Dae-Young (Department of Internal Medicine, Soonchunhyang University Bucheon Hospital) Chun, Hong-Woo (Department of Internal Medicine, Soonchunhyang University Bucheon Hospital) Kim, Bo-Young (Department of Internal Medicine, Soonchunhyang University Bucheon Hospital) Jeong, Shin-Ok (Department of Internal Medicine, Soonchunhyang University Bucheon Hospital) Lim, Sang-Hyok (Department of Internal Medicine, Soonchunhyang University Bucheon Hospital) Jang, An-Soo (Department of Internal Medicine, Soonchunhyang University Bucheon Hospital) |
1 | Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin Cutan Med Surg 1996;15:250-7. DOI |
2 | Cacoub P, Musette P, Descamps V, Meyer O, Speirs C, Finzi L, et al. The DRESS syndrome: a literature review. Am J Med 2011;124:588-97. DOI |
3 | Shear NH, Spielberg SP. Anticonvulsant hypersensitivity syndrome: in vitro assessment of risk. J Clin Invest 1988;82:1826-32. DOI |
4 | Descamps V, Valance A, Edlinger C, Fillet AM, Grossin M, Lebrun-Vignes B, et al. Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms. Arch Dermatol 2001;137:301-4. |
5 | Ichiche M, Kiesch N, De Bels D. DRESS syndrome associated with HHV-6 reactivation. Eur J Intern Med 2003;14:498-500. DOI |
6 | Picard D, Janela B, Descamps V, D'Incan M, Courville P, Jacquot S, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response. Sci Transl Med 2010;2:46ra62. |
7 | Tas S, Simonart T. Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): an update. Dermatology 2003;206:353-6. DOI |
8 | Tas S, Simonart T. Drug rash with eosinophilia and systemic symptoms (DRESS syndrome). Acta Clin Belg 1999;54:197-200. DOI |
9 | Callot V, Roujeau JC, Bagot M, Wechsler J, Chosidow O, Souteyrand P, et al. Drug-induced pseudolymphoma and hypersensitivity syndrome. Two different clinical entities. Arch Dermatol 1996;132:1315-21. DOI |
10 | Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994;331:1272-85. DOI |
11 | Palmero D, Castagnino J, Musella RM, Mosca C, Gonzalez Montaner P, de Casado GC. Difficult clinical management of anti-tuberculosis DRESS syndrome. Int J Tuberc Lung Dis 2013;17:76-8. DOI |
12 | Rodriguez R, Jover V, Orozco I, Domenech J. DRESS syndrome in a 19-year-old patient following the administration of first-line antituberculosis drugs. J Investig Allergol Clin Immunol 2012;22:380-1. |
13 | Kim JH, Jang SH, Kim DH, Park S, Kim DG, Jung KS. A case of DRESS syndrome induced by the antituberculosis drugs, prothionamide, and para-aminosalycilic acid. Ann Allergy Asthma Immunol 2013;110:118-9. DOI |
14 | Roujeau JC. Treatment of severe drug eruptions. J Dermatol 1999;26:718-22. DOI |